Think about how far we have come–the digital cloning of superstar Michael Jackson, rap icon Tupac Shakur and the beloved Mets baseball team. That’s just a sampling from the genius of John Textor, CEO of Pulse Evolution.
As Mr. Textor likes to say, this is just the beginning for his exciting company:
“We have quickly established ourselves as the early market leader in the creation of hyper-realistic digital humans for diverse applications.”
It was Pulse Evolution that brought the late Michael Jackson back to life, astonishing the masses globally during a live performance of the Billboard Music Awards on May 18, 2014. Jackson’s pixel perfection was captured beautifully and watched by more than 11 million television viewers. Instantly, more than 2,400 news articles and 98 billion Internet impressions popped up following the one-of-a kind virtual tribute performance.
A heavy portion of Pulse Evolution’s operating expenses comes from its development of digital humans and the exciting technology and entertainment properties that go with it.
Mr. Textor noted that a move to a national stock exchange is vital for the future of virtual reality and artificial intelligence:
“Our company was initially listed on OTC Markets to provide a linked security for our European Depositary Receipts, which were listed on the Frankfurt Stock Exchange in early 2014, helping us to raise more than $15 million through institutional investors to fund our launch phase. We now feel that our leading role in the advancing uses of digital humans, combined with significant interest from both financial and strategic partners, suggests strongly that we should move to fully reporting status and be recognized on a national exchange.”
Pulse Evolution cites operating expenses during the three months and the six months, ending December 31, 2014 were $3,452,673 and $7,024,761, respectively. Net loss attributable to the common shareholders, for the three months and six months, ending December 31, 2014, were $3,292,373 ($0.03 per share) and $6,511,536 ($0.05 per share), respectively.
The sale of common stock, net of fees, during the three months and the six months, ending December 31, 2014 shows proceeds of $2,096,588 and $4,253,309, respectively. Subsequent to the quarter ended December 31, 2014, and through August 20, 2015, proceeds achieved from the sale of preferred stock and common stock, sold in connection with two separate strategic partnerships, amounted to $5,020,000.